EUVIMEDObjevte EUVIMED
Crossref

Facile construction of gefitinib‐loaded zeolitic imidazolate framework nanocomposites for the treatment of different lung cancer cells

Kalaivani Aiyasamy, Malathi Ramasamy, Abdurahman Hajinur Hirad, Palanisamy Arulselvan, Ravindran Jaganathan, Jagadeesh Suriyaprakash, Indumathi Thangavelu iD, Abdullah A Alarfaj

Biotechnology and Applied Biochemistry · 2024

DOI: 10.1002/bab.2585 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2024. Written by Kalaivani Aiyasamy and 7 co-authors. Institution: Department of Biochemistry, Vivekanandha College of Arts and Sciences for Women (Autonomous), Tiruchengode, Namakkal, Tamil Nadu, India. Major MEDLINE topics: Lung Neoplasms, Zeolites, Antineoplastic Agents, Nanocomposites. Cited 3 times so far (Crossref); 59 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Gefitinib (GET) is a revolutionary targeted treatment inhibiting the epidermal growth factor receptor's tyrosine kinase action by competitively inhibiting the ATP binding site. In preclinical trials, several lung cancer cell lines and xenografts have demonstrated potential activity with GET. Response rates neared 25% in preclinical trials for non‐small cell lung cancer. Here, we describe the one‐pot synthesis of GET@ZIF‐8 nanocomposites (NCs) in pure water, encapsulating zeolitic imidazolate framework 8 (ZIF‐8). This method developed NCs with consistent morphology and a loading efficiency of 9%, resulting in a loading capacity of 20 wt%. Cell proliferation assay assessed the anticancer effect of GET@ZIF‐8 NCs on A549 and H1299 cells. The different biochemical staining (Calcein‐AM and PI and 4′,6‐Diamidino‐2‐phenylindole nuclear staining) assays assessed the cell death and morphological examination. Additionally, the mode of apoptosis was evaluated by mitochondrial membrane potential (∆ ψ m) and reactive oxygen species. Therefore, the study concludes that GET@ZIF‐8 NCs are pledged to treat lung cancer cells.

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsZeolitesAntineoplastic AgentsNanocompositesGefitinibHumansCell ProliferationMetal-Organic FrameworksImidazolesDrug Screening Assays, AntitumorApoptosisCell Line, TumorA549 Cells

Author keywords

apoptosisgefitiniblung cancernanocompositeszeolitic imidazolate framework

Substances

ZeolitesAntineoplastic AgentsGefitinibMetal-Organic FrameworksImidazoles

Authors and institutions

  • Department of Biochemistry, Vivekanandha College of Arts and Sciences for Women (Autonomous), Tiruchengode, Namakkal, Tamil Nadu, India.
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Department of Chemistry, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
  • Preclinical Department, Faculty of Medicine, Universiti Kuala Lumpur, Royal College of Medicine Perak (UniKL-RCMP), Perak, Malaysia.
  • Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, School of Information and Optoelectronic Science and Engineering, South China Normal University, Guangzhou, China.
  • Department of Chemistry, CHRIST (Deemed to be University), Bangalore, India.

ORCID profiles: Indumathi Thangavelu

Cite

APA

Aiyasamy, K., Ramasamy, M., Hirad, A. H., Arulselvan, P., Jaganathan, R., Suriyaprakash, J., Thangavelu, I., & Alarfaj, A. A. (2024). Facile construction of gefitinib‐loaded zeolitic imidazolate framework nanocomposites for the treatment of different lung cancer cells. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2585

Vancouver

Aiyasamy K, Ramasamy M, Hirad AH, Arulselvan P, Jaganathan R, Suriyaprakash J, et al. Facile construction of gefitinib‐loaded zeolitic imidazolate framework nanocomposites for the treatment of different lung cancer cells. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2585

BibTeX
@article{Aiyasamy2024,
  author = {Aiyasamy, Kalaivani and Ramasamy, Malathi and Hirad, Abdurahman Hajinur and Arulselvan, Palanisamy and Jaganathan, Ravindran and Suriyaprakash, Jagadeesh and Thangavelu, Indumathi and Alarfaj, Abdullah A},
  title = {Facile construction of gefitinib‐loaded zeolitic imidazolate framework nanocomposites for the treatment of different lung cancer cells},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2024},
  doi = {10.1002/bab.2585}
}
Start for free →